Mersana Therapeutics Inc (MRSN)

Q: Does MRSN pay dividends?

Mersana Therapeutics Inc (MRSN) does not currently pay a regular dividend.

Official site

BIOTECHNOLOGY

$29.08

+0.00 (+0.00%)

Last updated: Jan 06, 2026 at 4:00 PM ET

Earnings

Performance (10Y)

Beat Rate

41%(14/34)

Avg Surprise

-54.47%

Last 12 of 35 reported quarters

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Sep 30, 2025Sep 25 Reported Nov 14, 2025Reported Nov 14	$-1.51	$-0.14	$-0.68 - $0.15	-978.57%	Miss	3	3 0 30d	-1577.8%
Jun 30, 2025Jun 25 Reported Aug 13, 2025Reported Aug 13	$-4.87	$-0.16	$-1.16 - $2.09	-2943.75%	Miss	5	3 0 30d	-2335.0%
Mar 31, 2025Mar 25 Reported May 7, 2025Reported May 7	$-0.19	$-0.18	$-0.22 - $-0.17	-5.56%	Miss	5	No revisions (30d)	-18.8%
Dec 31, 2024Dec 24 Reported Feb 26, 2025Reported Feb 26	$-0.11	$-0.17	$-0.24 - $-0.11	+34.33%	Beat	5	5 0 30d	+31.3%
Sep 30, 2024Sep 24 Reported Nov 5, 2024Reported Nov 5	$-0.09	N/A	-	+51.35%	Beat	9	No revisions (30d)	+66.7%
Jun 30, 2024Jun 24 Reported Aug 13, 2024Reported Aug 13	$-0.20	$-0.17	$-0.25 - $-0.14	-17.65%	Miss	9	No revisions (30d)	+57.4%
Mar 31, 2024Mar 24 Reported May 9, 2024Reported May 9	$-0.16	$-0.18	$-0.21 - $-0.13	+11.11%	Beat	8	1 0 30d	+69.2%
Dec 31, 2023Dec 23 Reported Feb 28, 2024Reported Feb 28	$-0.16	$-0.16	$-0.39 - $0.23	+0.00%	Beat	9	1 0 30d	+63.6%
Sep 30, 2023Sep 23 Reported Nov 7, 2023Reported Nov 7	$-0.27	$-0.36	$-0.60 - $-0.24	+25.00%	Beat	9	No revisions (30d)	+55.7%
Jun 30, 2023Jun 23 Reported Aug 8, 2023Reported Aug 8	$-0.47	$-0.44	$-0.56 - $-0.11	-6.82%	Miss	9	4 0 30d	+14.5%
Mar 31, 2023Mar 23 Reported May 9, 2023Reported May 9	$-0.52	$-0.44	$-0.57 - $-0.16	-18.18%	Miss	8	No revisions (30d)	+11.9%
Dec 31, 2022Dec 22 Reported Feb 28, 2023Reported Feb 28	$-0.44	$-0.50	-	+12.00%	Beat	7	No revisions (30d)	+35.3%

Key Metrics

Valuation
P/E Ratio	N/A	EV/EBITDA	N/A
Price/FCF	N/A	FCF Yield	N/A
Profitability
Profit Margin	N/A	Operating Margin	N/A
ROE	N/A	ROIC	N/A
Financial Health
Debt/Equity	N/A	Interest Coverage	N/A
Current Ratio	N/A	Quick Ratio	N/A
Trading Statistics
Beta	N/A	Avg Volume	N/A
52-Week High	N/A	52-Week Low	N/A

Technical Indicators Dashboard

Moving Averages

SMA 10$28.96

SMA 20$28.75

SMA 50$22.88

SMA 200N/A

EMA 10$28.92

EMA 20$28.20

EMA 50$23.79

EMA 200$14.29

MACD

Line: 1.43Signal: 1.88Hist: -0.45

ADX

ADX: 69.6+DI: 39.9-DI: 8.5

Aroon & PSAR

Aroon Up96.0

Aroon DownN/A

PSAR$28.78

Bollinger Bands

Upper Band$29.54

Lower Band$27.97

%B Position546%(Upper)

Band Width0.71

RSI (14-Day)

Overbought

78.1

Momentum Oscillators

Stoch %K52.6

Stoch %D58.3

Williams %R-57.5

ROC (10d)0.5%

Momentum0.14

CCI (20d)69.3

MFI (14d)71.0

Volatility Measures

ATR (14d)$0.66(2.3%)

StdDev (20d)0.39

Hist Vol9.3%(Low)

Volume Flow

VWAP$29.08

OBV17.6M

AD Line86.1B

CMF (20d)-0.062

Volume Metrics

Avg Vol (20d)113.0K

Vol RatioN/A

VWMA (20d)$28.86

Pivot Points

R3$31.66

R2$31.03

R1$30.05

Pivot Point$29.42

S1$28.44

S2$27.81

S3$26.83

Advanced Oscillators

TSI61.67

Ultimate Osc49.2

KST592.91

Financial Data

Quarter	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022
Total Revenue	$11.01M	$3.06M	$2.75M	$16.36M	$12.60M	$2.29M	$9.24M	$10.70M	$7.70M	$10.65M	$7.80M	$14.69M
Cost of Revenue	$0	$0	$0	$400,000	$0	$0	$0	$447,000	$0	$0	$0	$282,000
Gross Profit	$11.01M	$3.06M	$2.75M	$16.36M	$12.60M	$2.29M	$9.24M	$10.70M	$7.70M	$10.65M	$7.80M	$14.69M

Operating Expenses	$18.68M	$27.57M	$27.27M	$31.17M	$24.67M	$27.75M	$30.25M	$32.13M	$51.64M	$67.16M	$65.60M	$60.51M
R&D	$12.18M	$16.22M	$18.34M	$22.29M	$14.80M	$17.25M	$18.69M	$21.50M	$30.53M	$48.97M	$47.27M	$45.71M
SG&A	$6.30M	$7.42M	$8.93M	$8.89M	$9.86M	$10.50M	$11.56M	$10.13M	$12.89M	$18.19M	$18.33M	$14.80M
Operating Income	$-7,667,000	$-24,517,000	$-24,512,000	$-14,811,000	$-12,069,000	$-25,455,000	$-21,001,000	$-21,427,000	$-43,941,000	$-56,501,000	$-57,801,000	$-45,826,000

Interest Income	$516,000	$895,000	$1.16M	$1.60M	$1.97M	$2.17M	$2.70M	$2.93M	$3.30M	$3.22M	$2.62M	$1.87M
Interest Expense	$394,000	$674,000	$775,000	$903,000	$986,000	$983,000	$1.00M	$1.05M	$1.02M	$1.02M	$983,000	$964,000
Income Before Tax	$-7,545,000	$-24,296,000	$-24,123,000	$-14,117,000	$-11,083,000	$-24,268,000	$-19,306,000	$-19,544,000	$-41,656,000	$-54,307,000	$-56,163,000	$-44,924,000
Income Tax Expense	$0	$0	$0	$0	$418,000	$0	$0	$0	$0	$0	$0	$0

Net Income	$-7,545,000	$-24,296,000	$-24,123,000	$-14,117,000	$-11,501,000	$-24,268,000	$-19,306,000	$-19,544,000	$-41,656,000	$-54,307,000	$-56,163,000	$-44,924,000

EBITDA	$-7,584,000	$-24,230,000	$-24,336,000	$-14,993,000	$-12,600,000	$-26,337,000	$-21,695,000	$-21,310,000	$-44,562,000	$-57,957,000	$-58,893,000	$-46,610,000
EBIT	$-7,667,000	$-24,517,000	$-24,512,000	$-14,811,000	$-12,069,000	$-25,455,000	$-21,001,000	$-21,427,000	$-43,941,000	$-56,501,000	$-57,801,000	$-45,826,000

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about MRSN

News

No news available

Company news will appear here when available

MRSN Competitors

Company	Ticker
Inovio Pharmaceuticals Inc	INO
Atrium Therapeutics, Inc. Common Stock	RNA
Sutro Biopharma	STRO
Sionna Therapeutics, Inc. Common Stock	SION
Innate Pharma	IPHA
MaxCyte Inc	MXCT
Anbio Biotechnology Class A Ordinary Shares	NNNN
MacroGenics Inc	MGNX

Sector: Healthcare

MRSN Bull Case vs Bear Case

Bear case

MRSN beat EPS estimates in 37.5% of its last 8 reported quarters.

MRSN Earnings: Beat Rate and Next Report

Beat rate: 3 of 8 quarters (37.5%)
Average surprise: -481.1%

MRSN Earnings Call

The latest MRSN earnings call transcript on file is labeled 2025Q2.

Read the 2025Q2 transcript

MRSN ETF Holders

GNG tracks 2 ETFs that hold MRSN. The largest weights:

Vanguard Total Stock Market Index Fund Admiral Shares (VTSAX), <0.01% of the fund
Vanguard Extended Market Index Fund ETF Shares (VXF), <0.01% of the fund

Open the ETF Stock Exposure tool for MRSN

See insider activity

Frequently Asked Questions About MRSN

Does MRSN pay dividends?